Endogenous IL-7 is associated with increased thymic volume in adult HIV-infected patients under highly active antiretroviral therapy

AIDS

Volumn 17, Issue 7, 2003, Pages 947-954

  Ruiz Mateos, Ezequiel ^a   De La Rosa, Rafael ^a   Franco, Jaime M ^a   Martinez Moya, Manuel ^b   Rubio, Amalia ^a   Soriano, Natalia ^a   Sanchez Quijano, Armando ^a   Lissen, Eduardo ^a   Leal, Manuel ^a,b  

^a UNIVERSITY OF SEVILLE   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Highly active antiretroviral therapy; HIV; IL 7; Immune reconstitution; Thymus

Indexed keywords

ANTIRETROVIRUS AGENT; INTERLEUKIN 7; T LYMPHOCYTE RECEPTOR; VIRUS RNA;

ADULT; ARTICLE; CELL REGENERATION; CLINICAL ARTICLE; COLORIMETRY; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; LYMPHOPOIESIS; MALE; ORGAN SIZE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; T LYMPHOCYTE; THYMUS; TREATMENT OUTCOME;

EID: 0038216950     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200305020-00002     Document Type: Article

References (34)

1. + T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 1995, 332:143-149.
2. Douek DR, McFarland P, Keiser E, Gage EA, Massey JM, Haynes BF, et al. Changes in thymic function with age and during treatment of HIV infection. Nature 1998, 396:690-695.
3. Zhang L, Lewin SR, Markowitz M, Lin HH, Skulsky E, Karanicolas R, et al. Measuring recent thymic emigrants in blood of normal and HIV-1-infected individuals before and after effective therapy. J Exp Med 1999, 190:725-732.
4. Teixeira L, Valdez H, McCune JM, Koup RA, Badley AD, Hellerstein MK, et al. Poor CD4 T-cell restoration after suppression of HIV-1 replication may reflect lower thymic function. AIDS 2001, 15:1749-1756.
5. McCune JM, Loftus R, Schmidt DK, Carroll P, Webster D, Swor-Yim LB, et al. High prevalence of thymic tissue in adults with human immunodeficiency virus-1 infection. J Clin Invest 1998, 11:2301-2308.
6. Franco JM, Rubio A, Martinez-Moya M, Leal M, Merchante E, Sánchez-Quijano A, et al. T cell repopulation and thymic volume in HIV-1-infected adult patients after highly active antiretroviral therapy. Blood 2002, 99:3702-3706.
7. Vigano A, Vella S, Saresella M, Vanzulli A, Bricalli D, Di Fabio S, et al. Early immune reconstitution after potent antiretroviral therapy in HIV-infected children correlates with the increase in thymus volume. AIDS 2000, 14:251-261.
8. Smith KY, Valdez H, Landay A, Spritzler J, Kessler HA, Connick E, et al. Thymic size and lymphocyte restoration in patients with human immunodeficiency virus infection after 48 weeks of zidovudine, lamivudine, and ritonavir therapy. J Infect Dis 2000, 181:141-147.
9. + T-lymphocytes regeneration after antiretroviral therapy in HIV-1 infected children and adult patients. Clin Exp Immunol 2000, 119:493-498.
10. von Freeden-Jeffry U, Vieira P, Lucian LA, McNeil T, Burdach SE, Murray R. Lymphopenia in interlekin-7 (IL-7) gene-deleted mice identifies IL-7 as a nonredundant cytokine. J Exp Med 1995, 181:1519-1526.
11. Namen AE, Schmierer AE, March CJ, Overell RW, Park LS, Urdal DL, et al. B cell precursor growth-promoting activity: purification and characterization of a growth factor active on lymphocyte precursors. J Exp Med 1988, 167:988-1002.
12. Namen AE, Lupton S, Hjerrild K, Wignall J, Mochizuki DY, Schmierer A, et al. Stimulation of B-cell progenitors by cloned murine inteleukin-7. Nature 1988, 333:571-573.
13. Henney CS. Interleukin 7: effects on early events in lymphopoiesis. Immunol Today 1989, 10: 170-173.
14. Murray R, Suda T, Wrighton N, Lee F, Zlotnik A. IL-7 is a growth and maintenance factor for mature and immature thymocyte subsets. Int Immunol 1989, 1:526-531.
15. Maki K, Sunaga S, Komagata Y, Kodaira Y, Mabuchi A, Karasuyama H, et al. Interleukin 7 receptor-deficient mice lack gamma-delta T cells. Proc Natl Acad Sci U S A 1996, 93:7172-7177.
16. Akashi K, Kondo M, Weissman IL. Role of interleukin-7 in T-cell development from hematopoietic stem cells. Immunol Rev 1998, 165:13-28.
17. Tan JT, Dudl E, LeRoy E, Murray R, Sprent J, Weinberg KI, et al. IL-7 is critical for homeostatic proliferation and survival of naïve T-cells. Proc Natl Acad Sci U S A 2001, 98:8732-8737.
18. Fry TJ, Christensen BL, Komschlies KL, Gress RE, Mackall CL. IL-7 restores immunity in athymic T-cell-depleted hosts. Blood 2001, 97:1525-1533.
19. Mackall CL, Fry TJ, Bare C, Morgan P, Galbraith A, Gress RE. IL-7 increases both thymic-dependent and thymic independent T-cell regeneration after bone marrow transplantation. Blood 2001, 97:1491-1497.
20. Okamoto Y, Douek DC, McFarland RD, Koup RA. Effects of exogenous interleukin-7 on human thymus function. Blood 2002, 99:2851-2858.
21. Fry TJ, Connick E, Falloon J, Lederman MM, Liewehr DJ, Spritzler J, et al. A potential role for IL-7 in T-cell homeostasis. Blood 2001, 97:2983-2990.
22. Napolitano LA, Grant RM, Deeks SG, Schmidt D, De Rosa SC, Herzenberg LA, et al. Increased production of IL-7 accompanies HIV-1 mediated T-cell depletion: implication for T-cell homeostasis. Nat Med 2001, 7:73-79.
23. + T-cell depletion and may be associated with emergence of SI variants in HIV-1+ individuals. J Virol 2001, 75:10319-10325.
24. Darcissac ECA, Vidal V, de la Tribonniere X, Mouton Y, Bahr GM. Variations in serum IL-7 and 90K/Mac-2 binding protein (Mac-2 BP) levels analices in cohorts of HIV-1 patients and correlated with clinical changes following antiretroviral therapy. Clin Exp Immunol 2001, 126:287-294.
25. Fry TJ, Mackall CL. Interleukin-7: master regulator of peripheral T-cell homeostasis? Trends Immunol 2001, 22:564-571.
26. Choyke PL, Zeman RE, Gootenberg JE, Greenberg JN, Hoffer F, Frank JA. Thymic atrophy and regrowth in response to chemotherapy: CT evaluation. Am J Roentgenol 1987, 149:269-272.
27. + T-cell repopulation in adult HIV-infected patients under highly active antiretroviral therapy. Antivir Ther 2002, 7:159-163.
28. Morrisey PJ, Conlon P, Braddy S, Williams DE, Namen AE, Mochizuki DY. Administration of IL-7 to mice with cyclophosphamide-induced lymphopenia accelerates lymphocyte repopulation. J Immunol 1991, 146:1547-1552.
29. Bolotin E, Smogorzewska M, Smith S, Widmer M, Weinberg K. Enhancement of thymopoiesis after bone marrow transplant by in vivo interleukin-7. Blood 1996, 88:1887-1894.
30. + T cell turnover in HIV-infected patients. Proc Natl Acad Sci USA 2000, 97:13778-13783.
31. Hazenberg MD, Stuart JW, Otto SA, Borleffs JC, Boucher CA, de Boer RJ, et al. T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART). Blood 2000, 95:249-255.
32. + thymocytes through sustained induction of Bcl-2. Blood 2001, 98:2166-2173.
33. + T cells. Proc Natl Acad Sci U S A 2001, 98:9277-9282.
34. Steffens CM, Managlia EZ, Landay A, Al-Harthi L. Interleukin-7-treated naive T-cells can be productively infected by T-cell-adapted and primary isolates of human immunodeficiency virus 1. Blood. 2002, 99:3310-3318.